Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Covidien plc    COV   IE00B68SQD29

End-of-day quote. End-of-day quote  - 01/26
106.71 USD   -1.26%
06/09DJDevice Maker Medtronic Wins U.S. Tax Case
2015 COVIDIEN : Announces Effectiveness of Medtronic Transaction Scheme o..
2015 COVIDIEN : Supports Retreat & Refresh Stroke Camp for Stroke Survivo..
SummaryQuotesChartsNewsCompany 
News SummaryMost relevantAll newsSector news 

Covidien plc : Covidien Recalls Duet TRS Staplers on Anatomical Injury Potential

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/22/2012 | 03:55pm CEST
   By Saabira Chaudhuri 
 

Covidien PLC (COV) is voluntarily recalling its Duet TRS staplers after receiving one report that links the tissue reinforcement material to a post-operative injury after abdominal surgery.

Launched in 2009, the product is a tissue reinforcement system to support staple lines. To date, Covidien has sold more than 540,000 worldwide.

Covidien on Wednesday said it has stopped manufacturing the units, after concluding that Duet TRS may have the potential to injure adjacent anatomical structures, which may result in life threatening post-operative complications.

The affected product codes range between 4535 to 6048A.

The most recent recall is in addition to one unveiled in January relating to the contraindication of the device in the thoracic cavity. At that time, Covidien received reports of 13 serious injuries and three fatalities following the application of Duet TRS in the thoracic cavity.

On Wednesday, the company said all Duet TRS products can be returned by emailing feedback.customerservice@covidien.com or calling 1-800-722-8772, option 1, to obtain a return goods authorization prior to returning the affected units.

People can report adverse events or quality problems related to the product by calling or emailing the Food and Drug Administration's MedWatch Adverse Event Reporting program.

Write to Saabira Chaudhuri at saabira.chaudhuri@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on COVIDIEN PLC
06/09DJDevice Maker Medtronic Wins U.S. Tax Case
2015 COVIDIEN : Announces Effectiveness of Medtronic Transaction Scheme of Arrangemen..
2015 COVIDIEN : Supports Retreat & Refresh Stroke Camp for Stroke Survivors and Careg..
2015DJCOVIDIEN : Earnings Rise on Growth in Surgical Sales
2015 COVIDIEN : Reports First-Quarter 2015 Results
2015DJEndo International to Join S&P 500 as Boston Beer Moves Up to MidCap List
2015 COVIDIEN : Announcement under Irish Takeover Rules Relevant Securities in Issue ..
2015 COVIDIEN : to Report First-Quarter Fiscal 2015 Results on January 22, 2015
2015 COVIDIEN : Announcement under Irish Takeover Rules Relevant Securities in Issue ..
2015DJCOVIDIEN : Files 8K - Other Events
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC

- No features available -

More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
2015 Tracking David Einhorn's Portfolio - Q1 2015 Update
2015 Tracking David Abrams' Abrams Capital Management Portfolio - Q1 2015 Update
2015 Pfizer's Once And Future Deals
2015 Why Medtronic-Covidien Deal Will Lead To Strong 2015 Performance
Advertisement
Chart COVIDIEN PLC
Duration : Period :
Covidien plc Technical Analysis Chart | COV | IE00B68SQD29 | 4-Traders
Full-screen chart
Managers
NameTitle
Gary Lee Ellis President, Chief Executive & Financial Officer
Steven M. McManama Chief Information Officer & Vice President
Michael Tarnoff Chief Medical Officer
Joy A. Amundson Director
Jacinta Lambert Director & Vice President-Finance
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
COVIDIEN PLC5.66%0
MEDTRONIC PLC13.70%121 878
ZIMMER BIOMET HOLDINGS..27.29%26 120
BAXTER INTERNATIONAL I..24.27%25 786
C R BARD INC16.33%16 187
TERUMO CORP10.38%15 192
More Results